Loading wribate...
Pharma
GLP-1 drugs such as semaglutide produce substantial weight loss, but many patients regain weight when they stop taking them. Critics say this creates open-ended dependence while food environments and lifestyles stay unchanged. Supporters say obesity is a chronic disease like high blood pressure, and that long-term treatment is as legitimate as any other.
No comments yet
Be the first to share your perspective